News Conference News ACC 2019 AUGUSTUS: Apixaban Plus P2Y12 Inhibitor the Best Combo in A-fib Patients With ACS or Undergoing PCI Caitlin E. Cox March 17, 2019
News Daily News Stay Away From Warfarin-Based Triple Therapy in Patients With A-fib and CAD, Study Affirms Todd Neale October 03, 2018
News Conference News TCT 2018 Twitter, Bias, and Trial Tweaks: ISCHEMIA Invites Debate on Study Designs and Endpoint Combos Michael O'Riordan October 02, 2018
News Conference News TCT 2018 OAC-ALONE: No Clear Answer for Best Therapy Beyond 1 Year After PCI in A-fib Patients Todd Neale September 24, 2018
Presentation TCT 2018 Is There Still a Role for Triple Therapy Based on Recent Studies? Presenter: Walter Desmet, Guy J. Friedrich September 22, 2018
Presentation TCT 2018 Case Conclusion Presenter: Philip M. Urban, Robert W. Yeh, Michael A. Kutcher, Michelle O'Donoghue, Elmir Omerovic, Manel Sabate, Daniel I. Simon, Giuseppe Tarantini September 22, 2018
Presentation TCT 2018 DAPT Duration Case Presentation #2: PCI in Stable CAD With LMCAD and MVD, Case Introduction Presenter: Philip M. Urban, Robert W. Yeh, Michael A. Kutcher, Michelle O'Donoghue, Elmir Omerovic, Manel Sabate, Daniel I. Simon, Giuseppe Tarantini September 22, 2018
Presentation TCT 2018 DAPT Duration Case Presentation #1: NSTEMI in a High Bleeding Risk Patient, Case Introduction Presenter: Philip M. Urban, Robert W. Yeh, Michael A. Kutcher, Michelle O'Donoghue, Elmir Omerovic, Manel Sabate, Daniel I. Simon, Giuseppe Tarantini September 22, 2018
Presentation TCT 2018 Stent Selection for 1-3 Month DAPT: Current Evidence, Ongoing Studies Presenter: Philip M. Urban, Robert W. Yeh, Stephan Windecker September 22, 2018
Presentation TCT 2018 Algorithmic Pharmacology Recommendations for the PCI Patient With Atrial Fibrillation Presenter: Philip M. Urban, Robert W. Yeh, C. Michael Gibson September 22, 2018
Presentation TCT 2018 Latest Thinking on DAPT Duration: Balancing Risk vs Benefit Presenter: Philip M. Urban, Robert W. Yeh, Tullio Palmerini September 22, 2018
Presentation TCT 2018 Atrial Fibrillation and ACS/PCI: The End of Triple Therapy? Presenter: Jeroen J. Bax, Stephan Windecker September 21, 2018
News Conference News ESC 2018 FFRCT Shifts Patient Management, Linked to Better 90-Day Outcomes: ADVANCE Registry Caitlin E. Cox September 07, 2018
News Daily News Genetic Risk Score Identifies Individuals at Heightened Risk of CAD and Other Diseases Michael O'Riordan August 16, 2018
News Daily News New Consensus Statement: NOAC and Clopidogrel for Most A-fib Patients Treated With PCI Michael O'Riordan July 31, 2018
News Daily News New Review Probes Possibility of CVD Prevention Without Aspirin Michael O'Riordan July 04, 2018
News Daily News Many Invasive Procedures, Including Cardiovascular, Up Risk of Infective Endocarditis Caitlin E. Cox June 11, 2018
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for April 2018 Caitlin E. Cox April 30, 2018
News Conference News SCAI 2018 Doctors, Risk Tools Often at Odds When Assessing Risks in Patients With A-fib Undergoing PCI Todd Neale April 27, 2018
News Daily News Less Bleeding, Similar Outcomes With Dual vs Triple Therapy After PCI in Patients With A-fib Todd Neale April 24, 2018